Facial Plast Surg
DOI: 10.1055/a-2778-9712
Original Research

Advances in Rhinoplasty Evidence: A Narrative Overview of Recent Meta-analyses (2015–2025)

Authors

  • David Ulrich Seidel

    1   Department of Otorhinolaryngology, Facial Plastic Surgery, Klinikum Oberberg, District Hospital Gummersbach, Germany
  • Nicole Rotter

    2   Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, Germany
  • Mark Scheithauer

    3   Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ulm, Germany
  • Olaf Ebeling

    4   Department of Otorhinolaryngology, Head and Neck Surgery, Ortenau Clinic Lahr, Germany
  • Simon Bode

    1   Department of Otorhinolaryngology, Facial Plastic Surgery, Klinikum Oberberg, District Hospital Gummersbach, Germany

Abstract

Introduction

Septoplasty and septorhinoplasty are key procedures in functional and aesthetic nasal surgery. Over the past decade, evidence on diagnostics, techniques, and outcomes has expanded significantly.

Objectives

To provide a structured summary of current evidence from systematic reviews and meta-analyses, focusing on diagnostics, surgical techniques, perioperative treatment, and patient-reported outcomes.

Study Design

Narrative review of 86 articles, reviews, and meta-analyses published within the past 10 years.

Methods

Studies were screened for relevance to functional and aesthetic rhinoplasty. Extracted data covered diagnostic methods, surgical techniques, medications, PROMs, and functional outcomes.

Results

Four-phase rhinomanometry offers promise but lacks validation. Body dysmorphic disorder (BDD) screening is gaining relevance. Evidence supports perioperative corticosteroids and tranexamic acid; routine antibiotics appear unnecessary. PROMs (NOSE, ROE, SNOT-22) are widely used.

Conclusion

Evidence for rhinoplasty is growing but heterogeneous. Standardized diagnostics, PROM-linked objective measures, and long-term data are needed to guide future patient-centered care.

Declaration of GenAI Use

Artificial intelligence (ChatGPT, OpenAI, San Francisco, USA, and DeepL SE, Cologne, Germany) was used for supporting tasks such as literature analysis, manuscript structuring, language editing, and translation.




Publication History

Received: 04 August 2025

Accepted after revision: 23 December 2025

Accepted Manuscript online:
29 December 2025

Article published online:
07 January 2026

© 2026. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA